Contact
searchSearch
HMP Global
Login

September 2016

Interview
How Financial Distress Can Affect Cancer Care
09/06/2016
Christopher S. Lathan, MD, MS, MPH
An interview with Christopher S Lathan, MD, MS, MPH, assistant professor of medicine, Harvard Medical School; faculty director, Cancer Care Equity Program; medical director, Dana-Farber Cancer Institute at St...
An interview with Christopher S Lathan, MD, MS, MPH, assistant professor of medicine, Harvard Medical School; faculty director, Cancer Care Equity Program; medical director, Dana-Farber Cancer Institute at St...
An...
09/06/2016
Journal of Clinical Pathways
Research in Review
Mayo Clinic Outlines Pathways for Thrombotic Microangiopathies
09/06/2016
Members of the Mayo Clinic in Rochester, MN, have provided guidelines for the creation of evidence-based clinical pathways for thrombotic microangiopathies (TMAs). TMAs are a diverse set of disorders sharing a...
Members of the Mayo Clinic in Rochester, MN, have provided guidelines for the creation of evidence-based clinical pathways for thrombotic microangiopathies (TMAs). TMAs are a diverse set of disorders sharing a...
...
09/06/2016
Journal of Clinical Pathways
Research in Review
Addition of Panobinostat to Multiple Myeloma Care Has Little Economic Impact
09/06/2016
Adding panobinostat to treatment regimens for multiple myeloma would have a minimal economic impact and could even save the health care system money, claims a study published in the Journal of Managed Care &...
Adding panobinostat to treatment regimens for multiple myeloma would have a minimal economic impact and could even save the health care system money, claims a study published in the Journal of Managed Care &...
...
09/06/2016
Journal of Clinical Pathways
Research in Review
Outcomes of Kidney-Sparing Surgery and Radical Nephroureterectomy Similar for Patients With Kidney Cancer
09/06/2016
Kidney-sparing surgery (KSS) and radical nephroureterecttomy (RNU) lead to similar survival for low-grade and noninvasive upper tract urothelial carcinoma (UTUC), according to a review published in European...
Kidney-sparing surgery (KSS) and radical nephroureterecttomy (RNU) lead to similar survival for low-grade and noninvasive upper tract urothelial carcinoma (UTUC), according to a review published in European...
...
09/06/2016
Journal of Clinical Pathways
Research in Review
Trastuzumab Cost Effectiveness Varies Based on Hormone Receptor Status
09/06/2016
How cost effective trastuzumab is for human epidermal growth factor receptor 2 (HER2)-positive breast cancer depends largely on patients’ age and hormone receptor status, according to a review published in PLOS...
How cost effective trastuzumab is for human epidermal growth factor receptor 2 (HER2)-positive breast cancer depends largely on patients’ age and hormone receptor status, according to a review published in PLOS...
How...
09/06/2016
Journal of Clinical Pathways
Research in Review
Patient-Reported Quality of Life Predicts Long-Term Lung Cancer Survival
09/06/2016
Patient-reported quality of life (QOL) may have prognostic value for long-term survival in disease-free survivors of surgically treated lung cancer who have completed active treatment, according to research...
Patient-reported quality of life (QOL) may have prognostic value for long-term survival in disease-free survivors of surgically treated lung cancer who have completed active treatment, according to research...
...
09/06/2016
Journal of Clinical Pathways
Editor's Page
A Greater Focus on the Patient
09/06/2016
Winston Wong, PharmD
One of the core goals of clinical pathways development has always been to make health care more patient-centered. However, a common complaint regarding clinical pathway development is that patients are often left out...
One of the core goals of clinical pathways development has always been to make health care more patient-centered. However, a common complaint regarding clinical pathway development is that patients are often left out...
One of...
09/06/2016
Journal of Clinical Pathways
Research Reports
Associations Between Pre- and Post-Cancer Depression Diagnoses and End-of-Life Cancer Care Intensity
09/06/2016
Becca R. Levy, PhD; Cary P. Gross, MD; Kathy Doan, MPH; Shi-Yi Wang, MD, PhD
Abstract: Literature suggests that depression has adverse effects on health outcomes among patients with cancer. However, the associations between depression and end-of-life (EOL) cancer care are inconclusive. In...
Abstract: Literature suggests that depression has adverse effects on health outcomes among patients with cancer. However, the associations between depression and end-of-life (EOL) cancer care are inconclusive. In...
...
09/06/2016
Journal of Clinical Pathways
Counterpoint
The Pivot Toward Patient-Centeredness in Medicine and Oncology
09/06/2016
Jennifer Fillman, MBA; Julia Braverman, PhD; Bruce A. Feinberg, DO
Patient-reported outcome (PRO) research has shown that PROs must play a role in the future of health care delivery as the system transitions from volume-based care to value-based care. Building trust among...
Patient-reported outcome (PRO) research has shown that PROs must play a role in the future of health care delivery as the system transitions from volume-based care to value-based care. Building trust among...
...
09/06/2016
Journal of Clinical Pathways
Counterpoint
Incorporating Routine Patient-Reported Outcomes Assessment Into Cancer Care: Building Momentum
09/06/2016
Edward Stepanski, PhD
While the collection and reporting of patient-reported outcome data in oncology trials and care settings has yet to reach its full potential, it has made some progress in recent years. Patient-reported outcomes...
While the collection and reporting of patient-reported outcome data in oncology trials and care settings has yet to reach its full potential, it has made some progress in recent years. Patient-reported outcomes...
...
09/06/2016
Journal of Clinical Pathways
JCP July-Aug Cover 2025

Current Issue

August 2025
Volume 11
Issue 4
Current Issue
Issue Archive

Special Reports

Special Report
Navigating the Management of Metastatic Colorectal Cancer in the Advanced Treatment Setting: Insights From an Expert Panel
08/15/2025
Tanios Bekaii-Saab, MD, FACP; Stacey Cohen, MD; Marwan Fakih, MD; Anwaar Saeed, MD
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the...
08/15/2025
Journal of Clinical Pathways
Special Report
Predictable Cost of Care Model for Treatment Decisions: Working Group Consensus Statements for Metastatic Non-Small Cell Lung Cancer
08/15/2025
Edward Arrowsmith, MD; Vishnukamal Golla, MD, MPH; Rhonda Henschel, MBA; Andrew Hertler, MD, FACP; David Jackman, MD; Gordon Kuntz; Olaf Lodbrok, MS, MBA; Carole Tremonti, RN, MBA; Lalan Wilfong, MD
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care...
08/15/2025
Journal of Clinical Pathways
Special Report
Navigating the Management of Metastatic Colorectal Cancer in the Advanced Treatment Setting: Insights From an Expert Panel
06/12/2025
Tanios Bekaii-Saab, MD, FACP; Stacey Cohen, MD; Marwan Fakih, MD; Anwaar Saeed, MD
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the...
06/12/2025
Journal of Clinical Pathways
Page 1
Special Report
Predictable Cost of Care Model for Treatment Decisions: Working Group Consensus Statements for Metastatic Non-Small Cell Lung Cancer
02/19/2025
Edward Arrowsmith, MD; Vishnukamal Golla, MD, MPH; Rhonda Henschel, MBA; Andrew Hertler, MD, FACP; David Jackman, MD; Gordon Kuntz; Olaf Lodbrok, MS, MBA; Carole Tremonti, RN, MBA; Lalan Wilfong, MD
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care...
02/19/2025
Journal of Clinical Pathways
JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
Robin T. Zon, MD, FACP, FASCO; Gordon Kuntz; Winston Wong, PharmD
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways

Subscribe

Journal of Clinical Pathways Newsletter

September 2016 Volume 2

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use